Bio-MEMS Devices

Abstract:

Global Bio-MEMS Devices Market to Reach $2.1 Billion by 2027

Amid the COVID-19 crisis, the global market for Bio-MEMS Devices estimated at US$991 Million in the year 2020, is projected to reach a revised size of US$2.1 Billion by 2027, growing at aCAGR of 11.6% over the period 2020-2027. Implantables, one of the segments analyzed in the report, is projected to record 12.1% CAGR and reach US$1.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Injectables segment is readjusted to a revised 9.5% CAGR for the next 7-year period.

The U.S. Market is Estimated at $292.4 Million, While China is Forecast to Grow at 11.1% CAGR

The Bio-MEMS Devices market in the U.S. is estimated at US$292.4 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$373.6 Million by the year 2027 trailing a CAGR of 11.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.2% and 9.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.4% CAGR.

Select Competitors (Total 49 Featured) -

• All Sensors Corporation
• Bluechiip Ltd.
• Cepheid, Inc.
• Debiotech SA
• Integrated Sensing Systems, Inc.
• Texas Instruments, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Current & Future Analysis for Bio-MEMS Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • TABLE 2: World 7-Year Perspective for Bio-MEMS Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027
  • TABLE 3: World Current & Future Analysis for Implantables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • TABLE 4: World 7-Year Perspective for Implantables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • TABLE 5: World Current & Future Analysis for Injectables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • TABLE 6: World 7-Year Perspective for Injectables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • TABLE 7: World Current & Future Analysis for Neural Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • TABLE 8: World 7-Year Perspective for Neural Implants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • TABLE 9: World Current & Future Analysis for Bionics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • TABLE 10: World 7-Year Perspective for Bionics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • TABLE 11: World Current & Future Analysis for ENT Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • TABLE 12: World 7-Year Perspective for ENT Implants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • TABLE 13: World Current & Future Analysis for Cardio-MEMS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • TABLE 14: World 7-Year Perspective for Cardio-MEMS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • TABLE 15: World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • TABLE 16: World 7-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027

III. MARKET ANALYSIS

• UNITED STATES
  • TABLE 17: USA Current & Future Analysis for Bio-MEMS Devices by Segment - Implantables and Injectables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 18: USA 7-Year Perspective for Bio-MEMS Devices by Segment - Percentage Breakdown of Value Sales for Implantables and Injectables for the Years 2020 & 2027
  • TABLE 19: USA Current & Future Analysis for Bio-MEMS Devices by Application - Neural Implants, Bionics, ENT Implants, Cardio-MEMS and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 20: USA 7-Year Perspective for Bio-MEMS Devices by Application - Percentage Breakdown of Value Sales for Neural Implants, Bionics, ENT Implants, Cardio-MEMS and Other Applications for the Years 2020 & 2027
• CANADA
  • TABLE 21: Canada Current & Future Analysis for Bio-MEMS Devices by Segment - Implantables and Injectables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 22: Canada 7-Year Perspective for Bio-MEMS Devices by Segment - Percentage Breakdown of Value Sales for Implantables and Injectables for the Years 2020 & 2027
  • TABLE 23: Canada Current & Future Analysis for Bio-MEMS Devices by Application - Neural Implants, Bionics, ENT Implants, Cardio-MEMS and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 24: Canada 7-Year Perspective for Bio-MEMS Devices by Application - Percentage Breakdown of Value Sales for Neural Implants, Bionics, ENT Implants, Cardio-MEMS and Other Applications for the Years 2020 & 2027
• JAPAN
  • TABLE 25: Japan Current & Future Analysis for Bio-MEMS Devices by Segment - Implantables and Injectables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 26: Japan 7-Year Perspective for Bio-MEMS Devices by Segment - Percentage Breakdown of Value Sales for Implantables and Injectables for the Years 2020 & 2027
  • TABLE 27: Japan Current & Future Analysis for Bio-MEMS Devices by Application - Neural Implants, Bionics, ENT Implants, Cardio-MEMS and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 28: Japan 7-Year Perspective for Bio-MEMS Devices by Application - Percentage Breakdown of Value Sales for Neural Implants, Bionics, ENT Implants, Cardio-MEMS and Other Applications for the Years 2020 & 2027
• CHINA
  • TABLE 29: China Current & Future Analysis for Bio-MEMS Devices by Segment - Implantables and Injectables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 30: China 7-Year Perspective for Bio-MEMS Devices by Segment - Percentage Breakdown of Value Sales for Implantables and Injectables for the Years 2020 & 2027
  • TABLE 31: China Current & Future Analysis for Bio-MEMS Devices by Application - Neural Implants, Bionics, ENT Implants, Cardio-MEMS and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 32: China 7-Year Perspective for Bio-MEMS Devices by Application - Percentage Breakdown of Value Sales for Neural Implants, Bionics, ENT Implants, Cardio-MEMS and Other Applications for the Years 2020 & 2027
• EUROPE
  • TABLE 33: Europe Current & Future Analysis for Bio-MEMS Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • TABLE 34: Europe 7-Year Perspective for Bio-MEMS Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027
  • TABLE 35: Europe Current & Future Analysis for Bio-MEMS Devices by Segment - Implantables and Injectables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 36: Europe 7-Year Perspective for Bio-MEMS Devices by Segment - Percentage Breakdown of Value Sales for Implantables and Injectables for the Years 2020 & 2027
  • TABLE 37: Europe Current & Future Analysis for Bio-MEMS Devices by Application - Neural Implants, Bionics, ENT Implants, Cardio-MEMS and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 38: Europe 7-Year Perspective for Bio-MEMS Devices by Application - Percentage Breakdown of Value Sales for Neural Implants, Bionics, ENT Implants, Cardio-MEMS and Other Applications for the Years 2020 & 2027
• FRANCE
  • TABLE 39: France Current & Future Analysis for Bio-MEMS Devices by Segment - Implantables and Injectables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 40: France 7-Year Perspective for Bio-MEMS Devices by Segment - Percentage Breakdown of Value Sales for Implantables and Injectables for the Years 2020 & 2027
  • TABLE 41: France Current & Future Analysis for Bio-MEMS Devices by Application - Neural Implants, Bionics, ENT Implants, Cardio-MEMS and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 42: France 7-Year Perspective for Bio-MEMS Devices by Application - Percentage Breakdown of Value Sales for Neural Implants, Bionics, ENT Implants, Cardio-MEMS and Other Applications for the Years 2020 & 2027
• GERMANY
  • TABLE 43: Germany Current & Future Analysis for Bio-MEMS Devices by Segment - Implantables and Injectables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 44: Germany 7-Year Perspective for Bio-MEMS Devices by Segment - Percentage Breakdown of Value Sales for Implantables and Injectables for the Years 2020 & 2027
  • TABLE 45: Germany Current & Future Analysis for Bio-MEMS Devices by Application - Neural Implants, Bionics, ENT Implants, Cardio-MEMS and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 46: Germany 7-Year Perspective for Bio-MEMS Devices by Application - Percentage Breakdown of Value Sales for Neural Implants, Bionics, ENT Implants, Cardio-MEMS and Other Applications for the Years 2020 & 2027
• ITALY
  • TABLE 47: Italy Current & Future Analysis for Bio-MEMS Devices by Segment - Implantables and Injectables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 48: Italy 7-Year Perspective for Bio-MEMS Devices by Segment - Percentage Breakdown of Value Sales for Implantables and Injectables for the Years 2020 & 2027
  • TABLE 49: Italy Current & Future Analysis for Bio-MEMS Devices by Application - Neural Implants, Bionics, ENT Implants, Cardio-MEMS and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 50: Italy 7-Year Perspective for Bio-MEMS Devices by Application - Percentage Breakdown of Value Sales for Neural Implants, Bionics, ENT Implants, Cardio-MEMS and Other Applications for the Years 2020 & 2027
• UNITED KINGDOM
  • TABLE 51: UK Current & Future Analysis for Bio-MEMS Devices by Segment - Implantables and Injectables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 52: UK 7-Year Perspective for Bio-MEMS Devices by Segment - Percentage Breakdown of Value Sales for Implantables and Injectables for the Years 2020 & 2027
  • TABLE 53: UK Current & Future Analysis for Bio-MEMS Devices by Application - Neural Implants, Bionics, ENT Implants, Cardio-MEMS and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 54: UK 7-Year Perspective for Bio-MEMS Devices by Application - Percentage Breakdown of Value Sales for Neural Implants, Bionics, ENT Implants, Cardio-MEMS and Other Applications for the Years 2020 & 2027
• REST OF EUROPE
  • TABLE 55: Rest of Europe Current & Future Analysis for Bio-MEMS Devices by Segment - Implantables and Injectables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 56: Rest of Europe 7-Year Perspective for Bio-MEMS Devices by Segment - Percentage Breakdown of Value Sales for Implantables and Injectables for the Years 2020 & 2027
  • TABLE 57: Rest of Europe Current & Future Analysis for Bio-MEMS Devices by Application - Neural Implants, Bionics, ENT Implants, Cardio-MEMS and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 58: Rest of Europe 7-Year Perspective for Bio-MEMS Devices by Application - Percentage Breakdown of Value Sales for Neural Implants, Bionics, ENT Implants, Cardio-MEMS and Other Applications for the Years 2020 & 2027
• ASIA-PACIFIC
  • TABLE 59: Asia-Pacific Current & Future Analysis for Bio-MEMS Devices by Segment - Implantables and Injectables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 60: Asia-Pacific 7-Year Perspective for Bio-MEMS Devices by Segment - Percentage Breakdown of Value Sales for Implantables and Injectables for the Years 2020 & 2027
  • TABLE 61: Asia-Pacific Current & Future Analysis for Bio-MEMS Devices by Application - Neural Implants, Bionics, ENT Implants, Cardio-MEMS and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 62: Asia-Pacific 7-Year Perspective for Bio-MEMS Devices by Application - Percentage Breakdown of Value Sales for Neural Implants, Bionics, ENT Implants, Cardio-MEMS and Other Applications for the Years 2020 & 2027
• REST OF WORLD
  • TABLE 63: Rest of World Current & Future Analysis for Bio-MEMS Devices by Segment - Implantables and Injectables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 64: Rest of World 7-Year Perspective for Bio-MEMS Devices by Segment - Percentage Breakdown of Value Sales for Implantables and Injectables for the Years 2020 & 2027
  • TABLE 65: Rest of World Current & Future Analysis for Bio-MEMS Devices by Application - Neural Implants, Bionics, ENT Implants, Cardio-MEMS and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 66: Rest of World 7-Year Perspective for Bio-MEMS Devices by Application - Percentage Breakdown of Value Sales for Neural Implants, Bionics, ENT Implants, Cardio-MEMS and Other Applications for the Years 2020 & 2027

IV. COMPETITION

• Total Companies Profiled: 49